UNSPSC 51343828: Darunavir/Ritonavir

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM800. This VA Drug Class (AM800) classifies this compound as belonging to the group ANTIVIRALS.

UNSPSC 51343828 Darunavir/Ritonavir is a Commodity code, but the recent state and local contract opportunities tagged under it show little relevant activity directly aligned with this antiretroviral pharmaceutical. The four most recent solicitations—a Seminole County naloxone and drug deactivation systems procurement, a Texas HHS direct-to-manufacturer prescription RFI, a Tampa Fire Department first-aid supplies IFB, and a Minnesota Multistate Cooperative Purchasing Alliance generic pharmaceuticals and OTC products RFP—span emergency medical supplies, pharmacy benefit management infrastructure, firefighting consumables, and broad-spectrum generic drug distribution, none of which specifically target or reference Darunavir/Ritonavir or HIV treatment regimens. The mismatch between the code's nominal scope (a specific branded antiretroviral combination) and the actual procurement activity suggests either tagging inconsistency in the underlying source system or that this Commodity code currently sees minimal direct state and local solicitation activity.

The issuing bodies represented include county health departments (Seminole County), state health and human services agencies (Texas HHS), municipal purchasing offices (City of Tampa), and regional cooperative purchasing alliances (Minnesota Department of Administration), indicating that when state and local entities do procure pharmaceutical products, the activity flows through diverse procurement channels and organizational structures. Geographically, the recent activity spans Florida, Texas, Minnesota, and Oregon, though the concentration of pharmacy-focused solicitations in higher-population states and the prevalence of cooperative purchasing arrangements suggest that specialized pharmaceutical procurement in state and local government may increasingly route through multi-jurisdictional contracts rather than individual agency buys. Without direct solicitation history under this Commodity code, firms focused on HIV treatment regimens should monitor the broader generic pharmaceutical and specialty drug RFP activity at state health departments and cooperative purchasing alliances as a proxy for potential entry points.